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Abstract: Pregnancy increases the requirements of certain nutrients, such as vitamins, to provide
nutrition for the newborn. The aim was to analyze the association between dietary intake of vitamins
during pregnancy and risk of having a small for gestational age (SGA) newborn. A matched
case-control study was conducted (518 cases and 518 controls of pregnant women) in Spain. Dietary
vitamin intake during pregnancy was assessed using a validated food frequency questionnaire,
categorized into quintiles. Odds ratios (ORs) and their 95% confidence intervals (CI) were estimated
with conditional regression logistic models. A protective association was observed between maternal
dietary intake of vitamins A and D and SGA. For vitamin B3 and B6, the observed protective effect
was maintained after adjusting for potential confounding factors. For vitamin B9, we found only an
effect in quintiles 3 and 4 (OR = 0.64; 95% CI, 0.41–1.00; OR = 0.58; 95% CI, 0.37–0.91). Protective
effect for vitamin B12 was observed in 4th and 5th quintiles (OR = 0.61; 95% CI, 0.39–0.95; OR = 0.68;
95% CI, 0.43–1.04). No associations were detected between dietary intake of vitamins B2, E and C
intake and SGA. Our results suggest a positive association between dietary vitamin intake during
pregnancy and the weight of the newborn, although more studies are necessary and there could be a
ceiling effect for higher intakes of some vitamins cannot be discarded.
Keywords: maternal nutrition; dietary vitamins intake; pregnancy; small for gestational age
1. Introduction
Low birth weight (LBW), which is defined as an infant’s birth weight ≤2500 g, is the major
determinant of perinatal morbidity and mortality [1]. Worldwide, between 15% and 20% of all births
are LBW, representing more than 20 million births a year; moreover, the majority occur in low- and
middle-income countries, particularly in the most vulnerable populations [2]. However, birthweight
depends directly on the gestational age and sex of the newborn. For this reason, gestational age should
be considered when evaluating factors related to weight at birth; accordingly, it is usual to work
directly with the concept of small for gestational age infant (SGA).
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Maternal risk factors associated with an increased risk of SGA can be classified into: preconception
factors (including socio-demographic characteristics such as marital and socioeconomic status
and chronic diseases such as chronic hypertension), and pregnancy related conditions (including
inadequate prenatal care and maternal risky behaviors such as maternal smoking, alcohol intake, other
drug use or inadequate diet patterns for example) [3–8]. SGA also affects long-term health; respiratory
infections, diabetes mellitus, obesity, heart disease as well as neuropsychiatric disorders have been
reported among children with antecedent of SGA [9].
Several lifestyle factors also have a clear impact on SGA. Among these, dietary habits (potentially
modifiable during pregnancy) may play an important role in its etiology as diet composition negatively
impacts fetoplacental growth and metabolic patterns. In fact, poor maternal nutritional intake during
pregnancy can also negatively impact the fetal genetic growth trajectory and can result in fetal growth
restriction [10–12]. Pregnancy increases the requirements of certain nutrients due to the need to provide
nutrition for the newborn [13]; for example, vitamins are essential elements for a mother’s normal
metabolism as well as for fetal development. For example, vitamin A is required for maintaining
adequate growth and development [14]. Deficient vitamin D status influences birth weight, SGA risk
and neonatal growth [15], as does the vitamin B complex. Few studies investigate the relationship
between dietary vitamin intake and SGA risk and they report contradictory results. In general, this
relationship is addressed through the consumption of multivitamin/mineral supplements [16–20].
Moreover, most have been conducted in low- and middle-income countries [21–23]. These studies
also show significant disparity in the reference time point: some studies take serum samples and cord
blood after birth [14,24,25] and some use direct information on the first, second and third gestation
term [21,23,26–28]. For these reasons, we aim to analyze the association between dietary intake of
vitamins during pregnancy and risk of having a SGA newborn in Spanish pregnant women.
2. Material and Methods
We conducted a matched case-control study. The study population included women who gave
birth to a singleton newborn in one of five hospitals of Eastern Andalusia (Spain): the University of
Jaen Hospital (UJH), Ubeda Hospital (UH), the University of Granada Hospitals (two centers) (UGH),
and Poniente Hospital (PH), serving a total of 1.8 million people. Case and control groups were
collected from 15 May 2012 to 15 July 2015. Ethical Approval for this study was given by the Ethics
Committees of the hospitals. All women included in the study signed an informed consent.
2.1. Cases
Eligibility criteria for cases were delivery of a single live newborn diagnosed as SGA, according
to the tables developed for the Spanish population [29], without congenital malformations during the
study period, and resident in the referral area of the hospital. Nineteen women declined to participate.
A total of 533 cases were selected from the public hospitals: 79 (UJH), 46 (UH), 369 (UGH), and 39 (PH).
2.2. Controls
A match pair by maternal age at delivery (±2 years) was selected within the week following
inclusion of a case in the same hospital. Eligible women were those having a non SGA newborn with
the same inclusion criteria for cases (residence in the referral area of the hospital and no congenital
malformations). Sixty-five women declined participation.
2.3. Data Collection
Three sources of data were used: (1) personal interviews (carried out within two days after
delivery); (2) clinical charts; and (3) prenatal care records. Information was obtained on the
following variables: mother’s demographic data (marital status, education level, age at the beginning
of the pregnancy, ethnicity, , socioeconomic class, and occupation), obstetric history (parity and
antecedent abortions, previous adverse perinatal outcomes), conditions during pregnancy (infections,
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preeclampsia, diabetes, and other obstetric conditions), smoking during pregnancy, prescribed and
over-the-counter drugs, prenatal care (number of visits and date of first visit), and birth weight
(weight in grams in the delivery room). Social class was classified based on the classification of the
Spanish Society of Epidemiology ranging from I (the highest) to V (the lowest): class I (managerial
and senior technical staff and freelance professionals); II (intermediate occupations and managers in
commerce); III (skilled non-manual workers); IV (skilled manual workers); and V (unskilled manual
workers) [30]. This classification is similar to that of the Black Report (document published by the
Department of Health in the United Kingdom, which was the report of the expert committee into
health inequality) [31]. Prenatal care utilization was measured by using the Kessner index (principal
adequacy of prenatal care utilization index in use in the United States today) includes information
about both the timing of prenatal care initiation and prenatal care visits after initiation [32].
Alcohol consumption before and during pregnancy was assessed by a structured questionnaire
in which number of drinks and type of drink on weekdays, weekends (including Friday evening),
and holidays (including the eve) were recorded.
2.4. Dietary Assessment
The baseline questionnaire included a semi-quantitative food frequency questionnaire (FFQ)
previously validated in Spanish women aged 18–74 years, with 136 items and open-label questions for
information about use of dietary supplements [33]. The questionnaire was based on typical portion
sizes and had nine options for the frequency of intake in the previous year for each food item (ranging
from never or almost never to ≥6 times/day). A dietitian updated the nutrient data bank using the
latest available information recorded in the food composition tables for Spain [34,35]. Nutrient scores
were computed using ad hoc computer software specifically developed for this purpose (for each food
item, frequency by nutrient composition of specified portion size). After computing total energy intake.
15 matched pairs were excluded because of unreliable dietary assessment (total energy intake above
4000 Kcal/day), leaving 518 pairs for analysis (518 cases; 518 controls).
2.5. Statistical Analysis
Food and nutrient intakes were adjusted for total energy intake using the residuals method for
cases and controls as is recommended by Willet et al. [36]. Energy-adjusted food or nutrient intakes
were categorized in quintiles. Analyses were performed using Stata 13 (College Station, TX, USA). Odds
ratios (ORs) and their 95% confidence intervals (CI) were estimated with conditional regression logistic
models, with adjustment for potential confounders such as energy intake, preeclampsia, education
level, pre-pregnancy body mass index (BMI), smoking, weight gain per week during pregnancy and
previous preterm/LBW newborn. BMI was calculated as weight (in kg) just before pregnancy divided
by height (in m) squared. Both weight and height were obtained from medical records of the women if
possible, and self reported if not. All p values are 2-tailed. Statistical significance was set at p < 0.05.
3. Results
Table 1 summarizes the baseline characteristics of women included in the analysis. The weight
gain during pregnancy and body mass index prior to gestation was higher among women in the
control group women (p < 0.001). Regarding marital status, there were more married women in
controls than in cases (p < 0.036). Classical risk factors such as previous preterm/LBW, smoking
during the pregnancy and preeclampsia were more frequent in women with an SGA infant (p < 0.001).
Intrauterine growth retardation was higher for cases compared to controls (p < 0.001).
Associations between dietary vitamin intake during pregnancy, categorized in quintiles, with risk
of SGA are shown in Table 2 (vitamins A, D and E) and Table 3 (vitamins C and B complex) according
to their lipophilic or hydrophilic character, respectively. Results from the adjusted analysis provide
evidence of a protective association between maternal dietary intake of vitamins A and D and SGA,
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and no association for vitamin E (Table 2). For vitamin D, there was a decreased risk of SGA with its
intake with the risk 38% less for quintile 5 compared with quintile 1.
Table 1. Description of the study population among healthy pregnant Spanish women for AGA
(Adequate for Gestational Age) and SGA (n = 1036).
Cases(SGA) Controls (AGA) p Value
518 518
n (%) n (%)
Marital status 0.036
Single 37 (7.1) 42 (8.1)
Living with partner 161 (31.1) 124 (23.9)
Married 320 (61.8) 352 (68.0)
Education level 0.084
Primary 112 (21.6) 93 (17.9)
High school—not finished 42 (8.1) 28 (5.4)
High school 185 (35.7) 190 (36.7)
University 179 (34.6) 207 (40.0)
Antecedent of preterm/Low Birth Weight (LBW) newborn 64 (12.4) 26 (5.0) <0.001
Smoking during current pregnancy 149 (28.8) 80 (15.4) <0.001
Preeclampsia 46 (8.9) 11 (2.1) <0.001
Intrauterine growth retardation 141 (27.2) 8 (1.5) <0.001
Kessner index (prenatal care) 0.737
Adequate 259 (50.0) 253 (48.8)
Intermediate 185 (35.7) 182 (35.2)
Inadequate 74 (14.3) 83 (16.0)
Cases (SGA) Controls (AGA) p Value
518 518
Mean (SD) Mean (SD)
Weight gain during pregnancy (g/week) mean (SD) 278 (121) 310 (114) <0.001
Pre-pregnancy BMI mean (SD) 23.1 (4.5) 23.9 (4.1) <0.001
Alcohol intake (g/week) mean (SD) 4.2 (18.5) 3.1 (15.2) 0.312
SGA: Small for Gestational Age; AGA: Adequate for Gestational Age; SD: Standard Deviation
Table 2. Level of intake of liposoluble vitamins during pregnancy among healthy Spanish women
(n = 1036).
Cases (n = 518) Controls (n = 518) SGA a
n (%) n (%) cOR b 95% CI aOR c 95% CI
Vitamin A (mg/day) (retinol)
Q1 (≤1.236) 135 (26.1) 104 (20.1) 1 (reference) 1 (reference)
Q2 (1.237–1.545) 80 (15.4) 104 (20.1) 0.59 * 0.40–0.87 0.58 * 0.37–0.90
Q3 (1.546–1.979) 106 (20.5) 103 (19.9) 0.81 0.55–1.18 0.89 0.58–1.37
Q4 (1.979–2.604) 103 (19.9) 104 (20.1) 0.75 0.51–1.11 0.77 0.50–1.19
Q5 (>2.604) 94 (18.2) 103 (19.9) 0.69 0.47–1.01 0.67 0.43–1.05
Vitamin D (µg/day) (calciferol)
Q1 (≤3.793) 112 (21.6) 104 (20.1) 1 (reference) 1 (reference)
Q2 (3.794–5.168) 124 (23.9) 104 (20.1) 1.11 0.76–1.61 1.12 0.73–1.72
Q3 (5.168–6.228) 105 (20.3) 103 (19.9) 0.95 0.64–1.41 0.94 0.61–1.47
Q4 (6.229–7.981) 97 (18.7) 104 (20.1) 0.89 0.61–1.31 0.84 0.54–1.30
Q5 (>7.981) 80 (15.4) 103 (19.9) 0.73 0.49–1.08 0.62 * 0.40–0.98
Vitamin E (mg/day) (α-tocopherol)
Q1 (≤3.793) 103 (19.9) 104 (20.1) 1 (reference) 1 (reference)
Q2 (3.794–5.168) 103 (19.9) 104 (20.1) 1 0.67–1.49 1.03 0.66–1.63
Q3 (5.168–6.228) 101 (19.5) 103 (19.9) 0.99 0.66–1.47 1.18 0.75–1.84
Q4 (6.229–7.981) 85 (16.4) 104 (20.1) 0.81 0.54–1.23 0.85 0.54–1.35
Q5 (>7.981) 126 (24.3) 103 (19.9) 1.26 0.85–1.87 1.36 0.87–2.13
a SGA: Small for Gestational Age; b cOR: Crude odds ratio and confidence intervals (95% CI) c aOR: Adjusted odds
ratio by energy intake, preeclampsia, education level, pre-pregnancy body mass index, smoking, weight gain per
week during pregnancy, and previous preterm/LBW newborn; * Association significant.
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Table 3. Level of intake of hydrosoluble vitamins during pregnancy among healthy Spanish women
(n = 1036).
Cases (n = 518) Controls (n = 518) SGA a
n (%) n (%) cOR b 95% CI aOR c 95% CI
Vitamin C (mg/day)
(ascorbic acid)
Q1 (≤151.84) 121 (24.4) 104 (20.1) 1 (reference) 1 (reference)
Q2 (151.85–201.05) 98 (18.9) 104 (20.1) 0.79 0.54–1.17 0.81 0.53–1.26
Q3 (201.06–253.52) 110 (21.2) 103 (19.9) 0.92 0.63–1.38 0.84 0.55–1.29
Q4 (253.53–322.23) 96 (18.5) 104 (20.1) 0.78 0.52–1.15 0.89 0.57–1.40
Q5 (>322.23) 93 (18.0) 103 (19.9) 0.76 0.51–1.13 0.83 0.53–1.31
Vitamin B1 (thiamine)
(mg/day)
Q1 (≤1.746) 138 (26.6) 104 (20.1) 1 (reference) 1 (reference)
Q2 (1.747–1.970) 94 (18.2) 104 (20.1) 0.68 * 0.47–0.99 0.66 0.43–1.02
Q3 (1.971–2.226) 106 (20.5) 103 (19.9) 0.78 0.53–1.13 0.69 0.45–1.05
Q4 (2.227–2.589) 90 (17.4) 104 (20.1) 0.64 * 0.44–0.95 0.70 0.45–1.08
Q5 (>2.589) 90 (17.4) 103 (19.9) 0.64 * 0.43–0.95 0.64 0.41–1.01
Vitamin B2 (riboflavine)
(mg/day)
Q1 (≤1.895) 120 (22.2) 104 (20.1) 1 (reference) 1 (reference)
Q2 (1.896–2.161) 101 (19.5) 104 (20.1) 0.84 0.57–1.23 0.76 0.49–1.16
Q3 (2.161–2.447) 101 (19.5) 103 (19.9) 0.85 0.59–1.24 0.80 0.52–1.23
Q4 (2.448–2.746) 95 (18.3) 104 (20.1) 0.79 0.54–1.16 0.80 0.52–1.24
Q5 (>2.746) 101 (19.5) 103 (19.9) 0.85 0.58–1.24 0.85 0.57–1.36
Vitamin B3 (niacin)
(mg/day)
Q1 (≤34.790) 137 (26.5) 104 (20.1) 1 (reference) 1 (reference)
Q2 (34.791–39.035) 127 (24.5) 104 (20.1) 0.96 0.67–1.37 0.88 0.58–1.32
Q3 (39.036–42.430) 74 (14.3) 103 (19.9) 0.53 * 0.35–0.79 0.46 * 0.29–0.73
Q4 (42.431–47.830) 100 (19.3) 104 (20.1) 0.73 0.49–1.07 0.74 0.48–1.16
Q5 (>47.830) 80 (15.4) 103 (19.9) 0.58 * 0.39–0.86 0.59 * 0.37–0.86
Vitamin B6 (pyridoxine)
(mg/day)
Q1 (≤1.949) 134 (25.9) 104 (20.1) 1 (reference) 1 (reference)
Q2 (1.950–2.257) 116 (23.4) 104 (20.1) 0.85 0.58–1.23 0.80 0.52–1.22
Q3 (2.258–2.508) 80 (15.4) 103 (19.9) 0.62 * 0.42–0.91 0.62 * 0.40–0.96
Q4 (2.509–2.858) 105 (20.3) 104 (20.1) 0.76 0.52–1.12 0.70 0.45–1.08
Q5 (>2.858) 83 (16) 103 (19.9) 0.62 * 0.42–0.93 0.69 0.43–1.08
Vitamin B9 (folic)
(µg/day)
Q1 (≤297.45) 138 (26.6) 104 (20.1) 1 (reference) 1 (reference)
Q2 (297.46–348.78) 97 (18.7) 104 (20.1) 0.68 * 0.46–0.99 0.71 0.46–1.09
Q3 (348.79–412.94) 86 (16.6) 103 (19.9) 0.61 * 0.41–0.90 0.64 0.41–1.00
Q4 (412.95–491.91) 77 (14.9) 104 (20.1) 0.54 * 0.36–0.81 0.58 * 0.37–0.91
Q5 (>491.91) 120 (23.2) 103 (19.9) 0.87 0.59–1.27 0.88 0.57–1.35
Continued




n (%) n (%) cOR 95% CI aOR * 95% CI
Q1 (≤6.633) 133 (25.7) 104 (20.1) 1 (reference) 1 (reference)
Q2 (6.634–8.067) 109 (21) 104 (20.1) 0.81 0.56–1.18 0.91 0.59–1.39
Q3 (8.068–10.314) 102 (19.7) 103 (19.9) 0.79 0.54–1.15 0.80 0.52–1.24
Q4 (10.315–13.562) 83 (16) 104 (20.1) 0.61 * 0.41–0.91 0.61 * 0.39–0.95
Q5 (>13.562) 91 (17.6) 103 (19.9) 0.70 0.48–1.03 0.68 0.43–1.04
a SGA: Small for Gestational Age; b cOR: Crude odds ratio and confidence intervals (95% CI) c aOR: Adjusted odds
ratio by energy intake, preeclampsia, education level, pre-pregnancy body mass index, smoking, weight gain per
week during pregnancy, and previous preterm/LBW newborn; * Significant association.
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Table 3 shows the level of intake of hydrosoluble vitamins in the case and control groups.
No association was detected between vitamin C and SGA. With respect to B complex vitamins,
excluding vitamin B2 (riboflavin), we found a protective effect that was not constant across quintiles
and did not follow a clear trend for the different elements. Vitamin B1 was associated with a protective
effect in quintiles 2, 4 and 5 in the crude analysis. This association disappeared after adjusting for
potential confounding variables. However, with grouping quintiles 2 to 5 for vitamin B1, the net effect
was an independent reduction of risk (ORa = 0.67; 95% CI, 0.48–0.94). For vitamin B3, a protective
effect was observed in the crude analysis and this protective effect was maintained after adjusting for
potential confounding factors.
A similar effect was observed for vitamin B6. There was a protective effect for quintiles 3 and 5.
The global effect of quintiles 3 to 5 versus 1 to 2 after controlling for potential confounding factors was
0.75 (95% CI, 0.57–0.99). For vitamin B9 (folic acid), we found an effect for quintiles 2, 3 and 4, but only
the latter two maintain an observed effect in multivariable models. In this case, pooling strata 2 to 5
versus quintile 1 had a protective effect (Ora = 0.70; 95% CI, 0.50–0.99). Finally, we found a protective
effect for vitamin B12 in the 4th and 5th quintiles (ORa = 0.61; 95% CI, 0.39–0.95; Ora = 0.68; 95% CI,
0.43–1.04) (Table 3).
In our study population, with a measured multivitamin/mineral supplements consumption of
22.8% and 23.6%, respectively, of cases and controls, we did not find an effect of multivitamin/mineral
supplements on SGA (ORa = 0.93; 95% CI, 0.66–1.29) (see Supplementary Table S1).
4. Discussion
We found an association between the intake of different vitamins and the risk of SGA. Vitamins
D, B1, B3 and B12 identified a protective effect for higher intakes, for vitamins A, B6 and B9 moderate
intakes was associated with a lower risk of SGA, and, no associations between dietary intake of
vitamins B2, E or C and SGA were found.
Inconsistent results in previous studies show significant disparity in terms of nutrients assessed,
methods used to evaluate diet and its nutrients (dietary intake: food frequency questionnaires, dietary
record or prospective dietary record; or serum measurements), epidemiologic study design, prospective
or retrospective collection of information, study population, sample size and setting (high, middle or
low income countries), and also in the effect studied: mean weight at birth, percentage of low weight
or SGA. These differences make the comparison of the results more difficult.
4.1. Interpretation and Clinical Significance of Findings
4.1.1. Vitamin A
We found a protective effect of vitamin A, but only for moderate intake. In a previous study by
Rajasingam et al., no association with SGA was found, although this study lacked inclusion of a control
group from the same populations and not all women consented to blood samples for measurements
of biomarkers [37]. Studies by Agarwal et al. and Gebremedhin et al. measured serum retinol after
delivery and did not observe significant differences; however, these studies were based on a sample size
of convenience, had a significant loss to follow-up or had been carried out in middle- or low-income
countries [14,38]. The existing significant disparity in terms of methods used to evaluate diet and its
involved nutrients could imply the need of studies with measurement of vitamin A levels to assess the
possible contribution of poor vitamin A status to duration of pregnancy. Studies with well-defined
objectives, adequate design, good methods of measuring the study variables, and enough study power
are needed to make a correct approach to this problem.
Watson and McDonald observed that high β-carotene and retinol intakes were associated with
decreased birthweight in a prospective cohort study of 439 European and Polynesian pregnant women
assessing diet by a 24-h recall and a 3-day food record [39]. In addition, Al-Qaisi et al. observed
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that maternal vitamin A levels were significantly lower when offspring were LBW in a cohort of 88
pregnant Iraqi women [40].
4.1.2. Vitamin D
For vitamin D, variable results have been reported. Studies in Western populations that did not
find any association with SGA include Baker et al, and Carmago et al., who used intake data. However,
these studies had difficulty in maintaining contact with participants or had a population sample from
Massachusetts complicating the generalizability of these associations to regions with more sunlight
exposure [26,41]. Rodriguez et al. and Morgan et al. [25,42] used biological markers, but were unable to
obtain samples from all eligible participants introducing possible selection bias. Lastly, an association
with low weight was not found by either Camargo et al. or Gale et al. based on dietary intake data and
serum determinations [41,43].
Nonetheless, vitamin D is an essential nutrient with well-established roles in calcium
metabolism [44], therefore, the positive effect we found is plausible. The majority of previous studies
are consistent with our results. Based on serum determinations, several studies report that maternal
vitamin D deficiency is associated with a higher frequency of SGA [15,21,45], or higher percentage
of LBW [15,21,46]. Finally, studies based on dietary intake report a positive association with birth
weight [39,47,48], and only Morgan’s study in Canada, reports a lower risk of LBW when levels of
cord blood vitamin D are below 50 nmol/L [24].
4.1.3. Vitamin E
Studies for vitamin E have described both a positive effect [22,49–51] and the absence of
association [37,52]: a heterogeneity which is independent of the method used to evaluate the
exposure and the level of development of the population studied. We found no association for
vitamin E, probably due to the little impact it has on growth development as it has antioxidant
properties fundamentally.
4.1.4. Vitamin B Complex
Concerning the vitamin B complex, there are few studies in pregnancy investigating all B complex
vitamins and most examine the effects of either riboflavin (B12) or folate (B9) alone or as part of a
multivitamin/mineral supplement. In studies where multivitamin/mineral supplements are used,
it is difficult to separate the effects of the individual B vitamins on the outcome studied. We have
found studies that report a positive association for vitamin B2 [53], B9 [23,26,28], and B12 [23,28,39],
while others have found an absence of effect for vitamin B9 [24,27,52,54] and B12 [24,26,54]. Our data,
in contrast, show a protective effect for B9 and B12, both of which have an important role in supporting
maternal and fetal health during pregnancy to build and preserve maternal stores and meet the needs
of rapidly growing tissues [55] and increase the risk of neural tube defects and may contribute to
preterm birth [54].
4.1.5. Vitamin C
We did not find association between vitamin C and SGA which could be attributed to the
fact that we studied a Mediterranean population with a high intake of fruits, mainly citrus,
and vegetables, although there are studies that have found an association between Vitamin C and
placental weight [37,53].
5. Multivitamin/Mineral Supplements
Recent systematic reviews report the ability of multivitamin/mineral supplements to decrease
the risk of birth defects and the frequency of LBW [16,17]. However, the evidence supporting this
comes principally from studies conducted in low- and middle-income countries, and suggests the
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effect is due to poor diet quality and diversity in poor resource settings [17]. Furthermore, these
studies did not consider possible adverse effects of supplementation. The population of southern Spain
is characterized by a high dietary diversity [56] so in principle the intake of multivitamin/mineral
supplements is not necessary.
6. Strengths and Limitations
The effect of the intake of vitamins during pregnancy should not be assessed in isolation; the intake
of vitamins rich food possibly has an additional role to the strictly metabolic effect of the vitamin and
cannot be replaced by complex multivitamin [57].
The strengths of our study are: (1) our sample is representative of a reference population of
around 12,000 healthy pregnant women attending the several Andalusian public hospitals; (2) we used
previously utilized Spanish fetal growth curves to define adequate size for gestational age [29]; (3) we
used a FFQ previously validated in the Spanish population [33,58] and previously used in Spanish
pregnant women [59]; (4) the control group was selected by density in the same hospitals as cases and
they represent the regular dietary vitamin intake of the reference pregnant female population from the
area serviced by those hospitals; and (5) it is possible establish a suitable temporal relation.
We should also note that the absence of a clear dose-response gradient suggests either a threshold
value below which the desired effect is not achieved or a saturation level above which greater intakes
are not associated with a higher benefit. This makes it difficult to study the role played by vitamins on
SGA and therefore these results should be further supported by a larger number of studies.
Our study also includes other limitations: (1) It was difficult to obtain exact information about
our principal exposure variable, i.e., dietary vitamin intake during pregnancy. However, to decrease
this limitation, we used a validated food frequency questionnaire [33,58]; (2) All questionnaires were
recorded after birth but before hospital discharge, with the intention of estimating the average dietary
intake during pregnancy. However, delivery and the last gestational week of pregnancy would
be unlikely to change their habitual gestational dietary patterns; (3) The information was taken by
midwives. This may introduce a classification bias as the participating women may want to respond
with answers they believe will please the midwives: A bias that would affect both groups and shift the
magnitude of the force of association toward the null value.
We cannot discard a memory bias, but if present, we think it will be a non-differential bias
as beforehand no relation between a particular food intake and SGA is assumed. Finally, residual
confounding cannot be completely ruled out.
7. Conclusions
In conclusion, a high consumption of vitamins D, B1, B3, and B12, and moderate intake of
vitamins A, B6 and B9 during pregnancy were associated with lower risk of SGA. Our results suggest a
positive association and a suitable temporal relation between dietary vitamin intake during pregnancy
and weight of the newborn, although there could be a ceiling effect for higher intakes of some vitamins.
From a public health point of view, it is desirable to reinforce maternal counseling and encourage
dietary vitamin intake during pregnancy to decrease risk of SGA newborns and secondarily reduce its
effects [1].
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/11/1277/s1,
Table S1: Multivitamin/mineral supplements during pregnancy among healthy Spanish women (n = 1036).
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